MARY DILLARD: Open Payments
NPI 1629561436 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 24 payments from 8 companies in 2025. Trend: 2023 $392 · 2024 $353 · 2025 $637
Food & beverage: $578Education: $60
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $222 |
| GENZYME CORPORATION | 6 | $175 |
| GlaxoSmithKline, LLC. | 4 | $91 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Optinose US, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| AERIN MEDICAL INC. | 1 | $19 |
Products named: DUPIXENT, NUCALA, INSPIRE, Xhance, NEFFY, VIVAER STYLUS.
Industry payments across GA — which companies pay providers there.
